These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9345277)

  • 1. The release mechanism of platelet-activating factor during shear-stress induced platelet aggregation.
    Iwamoto S; Kawasaki T; Kambayashi J; Ariyoshi H; Shinoki N; Sakon M; Ikeda Y; Monden M
    Biochem Biophys Res Commun; 1997 Oct; 239(1):101-5. PubMed ID: 9345277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet microparticles: a carrier of platelet-activating factor?
    Iwamoto S; Kawasaki T; Kambayashi J; Ariyoshi H; Monden M
    Biochem Biophys Res Commun; 1996 Jan; 218(3):940-4. PubMed ID: 8579618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
    Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets.
    Touqui L; Chignard M; Jacquemin C; Wal F; Vargaftig BB
    Experientia; 1984 Apr; 40(4):374-7. PubMed ID: 6714369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle.
    Touqui L; Jacquemin C; Dumarey C; Vargaftig BB
    Biochim Biophys Acta; 1985 Jan; 833(1):111-8. PubMed ID: 3967037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Binding of 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (thrombocyte activating factor) by plasma components. Exchange of the thrombocyte activating factor between lipoproteins and thrombocytes].
    Kulikov VI; Bergel'son LD
    Biokhimiia; 1984 Aug; 49(8):1310-5. PubMed ID: 6093897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
    Grigoriadis G; Stewart AG
    Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific binding of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) to the intact canine platelet.
    Janero DR; Burghardt B; Burghardt C
    Thromb Res; 1988 Jun; 50(6):789-802. PubMed ID: 3413730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of acetylhydrolase from platelets on aggregation with platelet-activating factor.
    Suzuki Y; Miwa M; Harada M; Matsumoto M
    Eur J Biochem; 1988 Feb; 172(1):117-20. PubMed ID: 3345757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
    Komuro Y; Imanishi N; Uchida M; Morooka S
    Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperativity between platelet-activating factor and collagen in platelet aggregation.
    Kojima S; Hagiwara H; Soga W; Sekiya F; Saito Y; Inada Y
    Biochem Biophys Res Commun; 1987 Jun; 145(2):915-20. PubMed ID: 3593379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB; Joseph D; Marlas G; Chevance LG
    Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets.
    Kloprogge E; Akkerman JW
    Biochem J; 1984 Nov; 223(3):901-9. PubMed ID: 6150705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding and internalization of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in washed rabbit platelets.
    Homma H; Tokumura A; Hanahan DJ
    J Biol Chem; 1987 Aug; 262(22):10582-7. PubMed ID: 3038889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
    Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
    Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
    Nunez D; Russo-Marie F; Benveniste J
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human platelets stimulated by thrombin produce platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when the degrading enzyme acetyl hydrolase is blocked.
    Touqui L; Hatmi M; Vargaftig BB
    Biochem J; 1985 Aug; 229(3):811-6. PubMed ID: 4052028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enantiomer and the positional isomer of platelet-activating factor.
    Tence M; Coëffier E; Polonsky J; Benveniste J
    Biochim Biophys Acta; 1983 Feb; 755(3):526-30. PubMed ID: 6824744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation.
    Nomura S; Nakamura T; Cone J; Tandon NN; Kambayashi J
    Cytometry; 2000 Jul; 40(3):173-81. PubMed ID: 10878559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.